“Pain Rounds” is a supplemental educational resource to be used in a fashion similar to a textbook. It is not intended to replace clinical training or to provide any kind of medical licensing or certification.
Hypothesis
After completion of the entire video series, pain fellows will feel more equipped to pursue neuromodulation procedures regardless of institutional variability.
Research Methods
- Needs-based assessment
- Pre-test/post-tests
Disclosures
The project was funded from 2018-2020 as an unrestricted educational research grant at the Johns Hopkins School of Medicine through Nevro Corporation. As is policy with unrestricted grants, the company provided the funding but had no control of content during this time. We promise unbiased videos that in no form promote any particular company.
Disclosures for "Pain Rounds" Host & Guests at Time of Filming
Kerry Bradley, MS
Senior Director, Research
Nevro Corporation
Stock Ownership: Abbott, Boston Scientific, Nevro Corporation
James Chao, MD, FACS
Medical Director
OasisMD Lifestyle Healthcare
Consultant: Boston Scientific
Tim Deer, MD, DABPM
President & CEO
The Spine & Nerve Centers of the Virginias
Consultant: Abbott, Vertos, Axonics, Flowonix, Saluda Medical, Vertos, SpineThera, Nalu, Cornerloc, SPR Therapeutics, Vertiflex
Advisory Board: Abbott, Flowonix, Nalu, SPR Therapeutics, Vertiflex
Equity Options: Bioness, Vertiflex, Axonics, Vertos, SpineThera, Saluda Medicals, Nalu, Cornerloc
Research Consultant: Abbott, Mainstay Medical, Saluda, SPR Therapeutics, Vertiflex
Patent Pending for the DRG Paddle Lead: Abbott
Shravani Durbhakula, MD
Assistant Professor & Pain Medicine Fellowship Director
Johns Hopkins School of Medicine
Advisory Board: BioTras
Research Funding: Nevro
Maged Guirguis, MD
System Chair of Interventional Pain Medicine
Ochsner Health System
Consultant: Nevro, Boston Scientific, Avanos
Research: Nevro, Boston Scientific, Avanos, Abbott, Neuros, SPR Therapeutic
Robert Levy, MD, PhD
President, International Neuromodulation Society
Editor-in-Chief, Neuromodulation: Technology at the Neural Interface
Consultant: Abbott, Saluda, Nuvectra, Nalu, Mainstay Medical
Stock Options >5%: Nalu, Bioness, Vertos, Nevro
Stock Ownership: Nevro
Sean Li, MD
Regional Medical Director
Premier Pain Centers
Consultant: Abbott, Avanos, Nalu, Nevro, Saluda, SI-Bone, Vertiflex, Vertos
Grant/Research Support: Avanos, Biotronik, Nevro, Vertiflex, Saluda, SPR
Advisory Board: Abbott, Biotras, Nalu, Nevro, Saluda
Stock Shareholder/Equity: Axonics, BioTras, National Spine and Pain Centers, Nevro, Suture Concepts
Neel Mehta, MD
Medical Director, Pain Medicine
Weill Cornell Medical College
Consultant: Nevro
Advisor: Nuvectra
Research Funds in the Past 12 Months: Boston Scientific, Nevro, Abbott, Medtronic
Susan Moeschler, MD
Associate Professor & Pain Medicine Fellowship Director
Mayo Clinic
Yeshvant Navalgund, MD
Assistant Professor, West Virginia University
Co-Founder, DNA Advanced Pain Treatment Center
Consultant: Nevro, Medtronic, Abbott, Nuvectra
Daniel Pak, MD
Anesthesiology & Pain Medicine
Massachusetts General Hospital, Harvard Medical School
Erika Petersen, MD
Associate Professor & Director of Functional and Restorative Neurosurgery
University of Arkansas for Medical Sciences
Research Support or PI for Funded Industry Research: Nevro, Medtronic, Neuros Medical, ReNeuron
Faculty/Consulting: Abbott DBS, Medtronic DBS, Nevro
Advisory Board (Stock Options): SynerFuse
Peter Staats, MD, MBA, FIPP, ABIPP, DABPM
Chief Medical Officer
National Spine & Pain Centers
Consulting & Research Grants: Medtronic, Boston Scientific, Nevro, Abbott, Saluda
Founder: electroCore
Shareholder: electroCore, SPR Therapeutics, Nalu